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1. Introduction 
Since human tetanus antitoxins are commercially 
produced for passive protection [ 11, it was of interest 
to study the qualitative and quantitative distribution 
of specific antibodies in several individual sera. Pre- 
liminary tests showed that in human hyperimmune 
sera, antibodies are mainly concentrated in the 
y-globulin fraction [2] . 
Human individual tetanus antibodies were isolated 
by means of a specific polyacrylamide-immunoad- 
sorbent [3,4]. The activity of the isolated antibodies 
was determined in viva by the mouse protection test 
[5] and in vitro by the Ramon flocculation test [6]. 
The isolated antitoxins were identified as belonging 
essentially to the IgG class of immunoglobulins. As 
human IgG consists of 4 distinct groups of molecules, 
known as the subclasses of IgG, and referred to as G 1, 
G2, G3 and G4 [7-l l] , the IgG subclasses of isolated 
tetanus antibody from several individuals were in- 
vestigated. Distributions of IgG subclasses of isolated 
tetanus antibodies were compared with IgG sub- 
classes in the corresponding whole sera. 
2. Experimental 
Human tetanus antibodies from 6 individual hyper- 
immunized donors (kindly given by the Swiss Serum 
and Vaccine Institute, Bern) with antibody titers in 
the range from 8-33 IU were isolated by means of a 
specific immunoadsorbent. The immunoadsorbent 
was based on the mechanical entrapment of antigens 
into a lattice of a highly cross-linked macroporous 
synthetic polyacrylamide gel, as previously reported 
by Carrel et al. [3,4]. 
North-Holland Publishing Company - Amsterdam 
In our experiments 7 ml of a monomer solution 
containing 6 g acrylamide and 2 g bis-acrylamide per 
100 ml water were mixed with 1 ml of highly purified 
tetanus toxoid containing 2100 LF and polymerized 
with ammonium peroxydisulphate and riboflavin as 
catalyst under light activation for 1 hr at 27”. Since 
oxygen inhibits polymerization, nitrogen was first 
passed through the monomer solution. The block of 
polymerized antigen gel was mechanically dispersed 
by forcing it through a needle with an inner diameter 
of 0.8 mm. The gel particles were repeatedly washed 
with 0.1 M Tris-NaCl buffer pH 7.5 until no more 
toxoid remained in the supernatant. The extent of in- 
solubilization was about 92% of the amount of antigen 
originally added, as determined by entrapment of 
tritium-labeled toxoid. 
A chromatographic column was packed with the 
toxoid-containing gel particles and connected to a UV 
absorptiometer and the adsorption was recorded at 
280 nm. After application of the serum samples on top 
of the antigen-containing column, the column was 
washed with 0.1 M Tris-NaCl buffer pH 7.5 until an 
absorbance of less than 0.01 was recorded in the 
effluent. The antibodies bound to the immuno- 
adsorbent were eluted with 0.2 M glycine-HCl buffer 
pH 2.3. After elution of the antibodies the columns 
were re-equilibrated with 0.1 M Tris-NaCl buffer pH 
7.5 and used again. 
The pH of the eluted antibodies was’adjusted to 
neutrality by buffer exchange on Sephadex G-25 
against 0.1 M Tris-NaCl buffer pH 7.5 and concentrated 
by pressure dialysis. The specificity of the isolated 
antibodies was tested in vivo by comparison with a 
standard sample of antitoxin with the L+-technique 
in mice [5] , or in vitro by the Ramon flocculation 
test [6]. The extent of adsorption was also tested in 
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vivo by collecting all the non-bound ballast proteins 
(washes) and reconcentrating them up to the original 
protein level. 
The IgG subclass distribution was tested by means 
of a radioimmuno-assay [12] . Four different immuno- 
adsorbents were prepared by coupling the globulin 
fractions of specific anti-subclass antisera to bromo- 
acetylcellulose. The binding of 1251-labeled Gl, G2, 
G3 and G4 myeloma proteins to these immunoadsorb- 
ents was inhibited quantitatively by isolated IgG anti- 
bodies. With this technique it was possible to detect 
0.05 /.tg of Gl, G2, G3 and G4 per ml. The presence 
of antibodies of the IgA and Iglvl classes in the isolated 
antitetanus antibodies was tested by the double diffu- 
sion technique. 
3. Results 
Antibodies from 6 individual donors were isolated. 
Except for donor D, all antibodies were of the IgG 
class. The IgG subclass distribution of the respective 
individual antibodies is summarized in table 1. In 5 
donors (A, B, C, D, E and F) the 4 IgG subclasses were 
present in the isolated antibodies in a percental 
distribution corresponding nearly to the subclass 
distribution in the original individual sera, as shown in 
table 2. Donors B and C (table 1) had a relatively high 
percentage of G4, but they also showed an increased 
G4 in the whole serum. Donor D had tetanus anti- 
bodies of the IgM class only, while in the original 
serum all IgG subclasses were present in a normal 
distribution. The in vitro and in vivo tests of the 
isolated antibodies showed that they still had a 
protective activity, but the antibody titer had 
decreased in the range of 50% (table 1) compared 
Table 1 







Gl G2 G2 G3 G3 G4 G4 
(nglml) 
(clglml) (%l (Crglml) (%I @g/ml) (%l Olglml) (%) 
A 5 22 13.0 58 7.0 32 1.2 5 1.2 5 
B 16 64 43.0 67 8.0 12.5 1.6 2.5 11.5 18 
c 9 55 43.0 78 9.0 16.5 1.6 3 1.5 2.5 
D** 4 _ 
16.0 
- - - _ - _ 
E 5 30 53.5 6.0 20 1.1 4 7 22.5 
F 10 25 16.0 64 5.0 20 1.7 7 2.2 9 
* Sum of the 4 subclasses. 
** Donor D had IgM type antibodies only. 
Table 2 







Gl G2 G3 G4 G4 
(mg/ml) 
(mg/ml) (%) (mg/ml) (%I (mg/ml) (%I 
A 8 8.0 4.2 52.5 3.1 39 0.4 5.0 0.3 3.5 
B 33 7.5 4.2 56 2.3 30.5 0.4 5.3 0.6 8.0 
C 17 11.3 7.4 65.5 3.1 27.5 0.5 4.4 0.3 2.6 
D 8 8.6 5.0 58 2.8 32.5 0.6 7 0.2 2.5 
E 8 9.1 4.6 50.5 3.2 35 0.6 6.5 0.7 8.0 
F 18 5.6 3.1 55.5 1.7 30 0.7 12.5 0.1 2.0 
* Sum of the 4 subclasses. 
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with the titers in the original serum samples (table 2) 
during the isolation and concentration processes. In 
each serum sample, between 0.2 and 1.5 IU could be 
detected in the ballast proteins (washes). 
4. Discussion 
A discussion concerning the problems of immune 
specificity is rendered extremely difficult because of the 
great number of different cell clones which participate 
in the antibody production and which are all able to 
embed the same antibody specificity into different 
classes of the antibody globulins as yG, yA and yM 
immunoglobulins [13,14]. In our experiments, how- 
ever, only the anti-tetanus toxoid activity of the IgG 
class of immunoglobulins was investigated. For this 
reason, the antibodies were isolated from serum of 
hyperimmunized donors. Considering the IgG subclass 
distribution in the isolated antibody fractions, all 4 
subclasses were present in a percental distribution 
corresponding to the distribution of IgG subclasses in 
the original sera: Gl carrying the major part of the 
antibody activity, followed by G2, G3 and G4. 
Previous studies on isolated human tetanus anti- 
bodies revealed a relative homogeneity when compared 
with the whole y-globulin of the donor [ 151. Yount 
et al. [ 161 found that anti-tetanus toxoid antibodies 
do consist primarily of the major IgGl-subgroup. In 
contrast to these studies, our results demonstrate a 
clear heterogeneity of the anti-tetanus IgG antibodies. 
The reason for this discrepancy may be due to techni- 
cal differences: we could accept that the methods 
applied by those investigators [ 15, 161 were less sen- 
sitive than the radioimmuno-assay used in our study. 
If we consider the antigenic heterogeneity of the 
tetanus toxoid used for the immunization, the heter- 
ogeneous antibody response is not surprising. 
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